TVTX Sale Disclosure
Dube Eric M · SEC Form 4 · Filed Sep 17, 2026
Sale
Calculated transaction value
$197.42K
Dube Eric M Chief Executive Officer
TVTX
Travere Therapeutics
TVTX
Transaction date
Sep 15, 2026
Public filing date
Sep 18, 2026
Filing lag
Filed 3 days later
TVTX daily price context
Close on/before transaction
$62.51
Sep 15, 2026
Close before public filing
$64.74
Sep 17, 2026
Return since public filing
-3.06%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,102 shares @ $63.64
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001763494-26-000007
Filing cohort
Transactions in this filing
Showing 14 of 14
Trades
14
Issuers
1
Estimated value
$34.73M
Buys / sales
0 / 8
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Travere Therapeutics, Inc. TVTX | Sale | Sep 17, 2026 | $6.57M |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 17, 2026 | $2.53M |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 17, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 17, 2026 | $441.8K |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 16, 2026 | $4.57M |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 16, 2026 | $6.12M |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 16, 2026 | $6.31M |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 16, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $2.23M |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 15, 2026 | $3.94M |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX Current | Sale | Sep 15, 2026 | $197.42K |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 15, 2026 | $17.63K |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 15, 2026 | $1.8M |